CALABRO', Paolo
 Distribuzione geografica
Continente #
EU - Europa 23.917
AS - Asia 9.553
NA - Nord America 9.045
SA - Sud America 1.846
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 44.532
Nazione #
RU - Federazione Russa 16.481
US - Stati Uniti d'America 8.888
SG - Singapore 3.730
IE - Irlanda 2.467
CN - Cina 2.178
HK - Hong Kong 1.681
BR - Brasile 1.578
GB - Regno Unito 930
IT - Italia 884
UA - Ucraina 879
DE - Germania 763
VN - Vietnam 567
KR - Corea 438
FR - Francia 406
IN - India 310
SE - Svezia 306
FI - Finlandia 269
GR - Grecia 219
TR - Turchia 209
AR - Argentina 118
AT - Austria 94
JP - Giappone 93
BD - Bangladesh 66
MX - Messico 65
CA - Canada 60
ID - Indonesia 58
BE - Belgio 49
ZA - Sudafrica 43
EC - Ecuador 42
PK - Pakistan 37
IQ - Iraq 36
NL - Olanda 34
PL - Polonia 31
CO - Colombia 28
EG - Egitto 28
MA - Marocco 25
VE - Venezuela 21
ES - Italia 20
KE - Kenya 20
UZ - Uzbekistan 20
LT - Lituania 18
CL - Cile 15
PE - Perù 14
PY - Paraguay 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
EU - Europa 12
JO - Giordania 12
IR - Iran 11
NP - Nepal 10
SA - Arabia Saudita 10
TH - Thailandia 10
TN - Tunisia 10
CZ - Repubblica Ceca 8
RS - Serbia 8
CH - Svizzera 7
CR - Costa Rica 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
KZ - Kazakistan 6
OM - Oman 6
PA - Panama 5
RO - Romania 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
NG - Nigeria 4
NO - Norvegia 4
AM - Armenia 3
HN - Honduras 3
MY - Malesia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BO - Bolivia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AN - Antille olandesi 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
Totale 44.507
Città #
Moscow 5.591
Dublin 2.451
Santa Clara 1.888
Hong Kong 1.677
Jacksonville 1.376
Singapore 1.284
Chandler 1.101
Hefei 505
Seoul 427
Princeton 362
Roxbury 276
Ashburn 259
Beijing 246
Medford 241
Bengaluru 225
The Dalles 213
Ho Chi Minh City 207
Boardman 199
New York 196
Naples 157
Wilmington 145
Bremen 138
Cambridge 132
Houston 127
Ann Arbor 124
Dallas 119
Hanoi 117
São Paulo 117
Woodbridge 106
Nuremberg 105
San Mateo 105
Des Moines 84
Nanjing 61
Los Angeles 59
Rio de Janeiro 56
Munich 55
Falkenstein 53
Mountain View 49
Düsseldorf 48
Brussels 45
Belo Horizonte 37
Norwalk 37
Guangzhou 35
Milan 35
Curitiba 34
Vienna 34
Caserta 32
Aversa 31
Da Nang 31
Brasília 30
Helsinki 28
Rome 28
Jinan 27
Brooklyn 25
Turku 25
Porto Alegre 24
Haiphong 23
Johannesburg 23
Shanghai 23
Ercolano 22
Hyderabad 22
Lappeenranta 22
London 22
Campinas 21
Tianjin 21
Columbus 20
Nanchang 20
Boston 19
Salvador 19
Changsha 18
Hangzhou 18
Mexico City 18
Napoli 18
Philadelphia 18
Shenyang 18
Nairobi 17
Tashkent 17
Amsterdam 16
Frankfurt am Main 16
Istanbul 16
San Francisco 16
San Giovanni In Fiore 16
Thái Bình 16
Baghdad 15
Dhaka 15
Guayaquil 15
Redwood City 15
Tokyo 15
Toronto 15
Zhengzhou 15
Cairo 14
Jakarta 14
Guarulhos 13
Quito 13
Stockholm 13
Amman 12
Casablanca 12
Hải Dương 12
Kraków 12
Montreal 12
Totale 21.966
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 211
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 190
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy? 174
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 165
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 161
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 160
. Accuratezza predittiva dell'elettrocardiogramma nell'identificazione dell'ipertrofia ventricolare sinistra. 156
Activated coagulation factor VII promotes smooth muscle cell proliferation in vitro. 153
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience 153
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 152
Adipose tissue and vascular inflammation in coronary artery disease. 151
Advanced Heart Failure in Special Population—Pediatric Age 150
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy 146
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 146
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 143
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 142
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. 141
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 141
Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. 140
A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation 140
Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS 140
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy 140
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 140
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery Surgery After Stenting 2 139
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 139
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? 138
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 138
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) 138
A new character on the scene of cardiorenal syndrome 137
Association between left atrial myocardial function and exercise capacity in patients with either idiophatic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study 137
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 135
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 135
Natural history of left ventricular hypertrophy in infants of diabetic mothers 135
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 134
Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals 133
Childhood obesity: An overview of laboratory medicine, exercise and microbiome 133
. Left atrial strain/strain rate analylisis in patients with dilated cardiomyopathy. Correlation with clinical, electrocardiographic and echocardiographic findings 132
.: Correlations between right ventricular myocardial function and cardiac performance during exercise in adult patients late after repair of tetralogy of Fallot 132
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team 131
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 131
[Device therapy in chronic heart failure: a case of hypertrophic cardiomyopathy treated with cardiac contractility modulation therapy] 130
[The COMPASS study] 130
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 129
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 129
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 129
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 128
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation 128
. L’analisi DMI del ventricolo destro a riposo predice la performance all’apice dello sforzo dei pazienti adulti operati per tetralogia di Fallot 128
. Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle 128
. Plasma CT1 analysis in patients with hypertrophic cardiomyopathy. 127
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 126
Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare. 126
Activated platelets stimulate tissue factor expression in smooth muscle cells 126
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 126
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A contemporary reappraisal 125
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry) 124
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 124
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 123
Obesità in età pediatrica ed ipertensione arteriosa 123
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 122
Impact of GEne Polymorphisms, Platelet REactivity and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 121
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 120
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy 120
Feasibility and usefulness of right ventricular ultrasonic tissue characterization with integrated backscatter in patients with unsuccessfully operatively "repaired" tetralogy of Fallot 120
. Integrated backscatter analysis of functional and textural findings in young patients with different pathophysiological models of right ventricular overload 120
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target 119
Registrazione del potenziale di azione monofasico e del recupero ventricolare a seguito di variazioni acute del sovraccarico di volume: evidenza in vivo del feedback elettromeccanico 119
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 119
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 118
Effect of body mass index reduction on serum hepcidin levels and iron status in obese children 118
Hypertrophic cardiomyopathy in a girl with Cornelia de Lange syndrome due to mutation in SMC1A. 116
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 116
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 115
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 115
Global longitudinal speckle-tracking strain is predictive of left ventricular remodeling after coronary angioplasty in patients with recent non-st elevation myocardial infarction. 115
Induction of tissue factor in the arterial wall during recurrent thrombus formation 115
Nutcracker syndrome. 115
Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives 114
Update of the position document of the Italian Society of Interventional Cardiology (SICI-GISE) on the minimum requirements for hospitals and operators performing procedures of a transcatheter implantation of aortic valve prostheses 114
[Evaluation and percutaneous treatment of severely calcified coronary lesions] 114
Cardiac involvement in systemic sclerosis: 'early diagnosis-early management' approach 113
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 112
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 112
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 112
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions 111
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 111
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 111
The athlete’s heart and hypertrophic cardiomyopathy: two conditions which may be misdiagnosed and coexistent. Which parameters should be analysed to distinguish one disease from the other? 111
Left ventricular non compaction in children. 111
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 111
Hepcidin in Obese Children as a Potential Mediator of the Association between Obesity and Iron Deficiency. 110
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease 110
The left atrial appendage: from embryology to prevention of thromboembolism 109
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 109
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 109
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 108
Potential clinical perspectives of Doppler myocardial imaging and strain rate imaging during stress echocardiography 108
Visceral adiposity and arterial stiffness: Echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives 108
Echocardiographic evaluation of left ventricular systolic function in the down syndrome 108
Increased hepcidin levels in childhood obesity: the missed link between adiposity and disrupted iron metabolism 108
Totale 12.908
Categoria #
all - tutte 159.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.154 0 0 0 0 0 14 308 190 30 244 285 83
2021/20222.391 130 13 26 82 785 27 36 148 86 184 147 727
2022/20234.257 452 145 58 348 401 307 10 206 2.136 32 78 84
2023/20242.109 144 59 76 161 680 223 86 74 12 57 155 382
2024/20257.551 26 74 35 213 1.164 1.071 1.092 614 956 1.186 644 476
2025/202623.723 1.110 1.499 1.630 1.544 2.338 15.602 0 0 0 0 0 0
Totale 45.480